Brought to you by 
Pfenex grants protein production rights to Merck
05 Jan 2010
Executive Summary
Protein production company Pfenex has granted Merck exclusive worldwide rights to its Pfenex Expression Technology for use in the development of a new undisclosed vaccine.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Drug Discovery Tools
- Large Molecule
- Synthesis Technologies, Production Processes
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com